HORVATH v. GLOBE LIFE AND ACCIDENT INSURANCE COMPANY

CourtDistrict Court, W.D. Pennsylvania
DecidedAugust 27, 2019
Docket3:18-cv-00084
StatusUnknown

This text of HORVATH v. GLOBE LIFE AND ACCIDENT INSURANCE COMPANY (HORVATH v. GLOBE LIFE AND ACCIDENT INSURANCE COMPANY) is published on Counsel Stack Legal Research, covering District Court, W.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
HORVATH v. GLOBE LIFE AND ACCIDENT INSURANCE COMPANY, (W.D. Pa. 2019).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF PENNSYLVANIA TAMMY HORVATH, ) Case No. 3:18-cv-84 ) Plaintiff, ) JUDGE KIM R. GIBSON ) v. ) ) GLOBE LIFE AND ACCIDENT ) INSURANCE COMPANY, ) ) Defendant. ) MEMORANDUM OPINION I. Introduction Before the Court is Defendant Globe Life and Accident Insurance Company’s (“Defendant”) Motion for Partial Summary Judgment (ECF No. 20). The Motion is fully briefed (ECF Nos. 21, 22, 23, 24, 25, 26, 35, 36, 40, 41) and is ripe for disposition. For the reasons that follow, Defendant's Motion is GRANTED IN PART and DENIED IN PART. II. Subject-Matter Jurisdiction & Venue The Court has diversity jurisdiction over this case pursuant to 28 U.S.C. § 1332(a)(1) because Plaintiff Tammy Horvath (“Plaintiff”) is a citizen of a different state than Defendant and the amount in controversy exceeds $75,000. (ECF No. 1 {{ 1-3.) Venue is proper in the Western District of Pennsylvania under 28 U.S.C. § 1391(b)(2), as a substantial portion of the events and omissions giving rise to Plaintiff's claims occurred in this District.

III. Background A. Factual History! 1.The Applications and Policies On January 26, 2016, Plaintiff applied for a life-insurance policy for her son, Luke Yuzwa, in the amount of $30,000. (ECF No. 22 J 1; ECF No. 23 { 1.) The application asked the following question about Mr. Yuzwa’s health (“Question 4(a)”): (a)Within the past 3 years, have any of the Proposed Insured(s) had any chronic illness or condition which requires periodic medical care? (ECF No, 22 { 2; ECF No. 23 2; ECF No. 23-2 □ 1; ECF No. 25 { 1.)? The application did not define the terms “chronic illness” or “condition,” nor did it provide a list of medical conditions which would qualify as either a “chronic illness” or “condition.” (ECF No. 23-2 J{ 2, 4; ECF No. 25 {1 2, 4.) The application also did not define “periodic medical care” or otherwise indicate what length or frequency of visits qualifies as “periodic medical care.” (ECF No. 23-2 {{ 3, 5; ECF No. 25 {J 3, 5.) The application failed to ask any specific questions regarding the use of alcohol, marijuana, or other drugs, or about dependency on or addiction to alcohol or drugs. (ECF No. 23-2 {J 35-36; ECF No. 25 J 35-36.) Plaintiff answered Question 4(a) in the negative. (ECF No. 22 { 3; ECF No. 23 { 3.) Defendant approved the application and issued Policy 008F85062. (ECF No. 22 { 4; ECF No. 23

'The Court derives these facts from a combination of ECF Nos. 22, 23, 25, 35, and 40. These facts are undisputed unless otherwise noted. The Court includes additional facts in Section V, infra, as necessary. 2 Plaintiff's counter-statement of material facts, which is contained within the same document as its responsive concise statement of material facts, uses the same paragraph numbers as its responsive concise statement. (See ECF No. 23.) Therefore, the Court cannot cite to, e.g., 1,” because there are two such paragraphs within the same document. To refer to the responsive concise statement, the Court will cite to ECF No. 23. To refer to the counter-statement, the Court will cite to ECF No. 23-2.

1 4.) On February 22, 2016, Plaintiff applied for a second life-insurance policy for Mr. Yuzwa in the amount of $25,000. (ECF No. 22 ECF No. 23 {7.) The application again asked Question 4(a) about Mr. Yuzwa’s health. (ECF No. 22 { 8; ECF No. 23 { 8; ECF No. 23-2 J 1; ECF No. 25 1.) The application did not define the terms used in Question 4(a). (ECF No. 23-2 {{ 2-3, 6-7; ECF No. 25 2-3, 6-7.) Plaintiff answered Question 4(a) in the negative. (ECF No. 22 ¥ 9; ECF No. 23 { 9.) Defendant approved the application and issued Policy 008G98329. (ECF No. 22 ¥ 11; ECF No. 23 q 11.) On April 12, 2016, Plaintiff completed online applications seeking to increase coverage on Policy 008F85062 and Policy 008G8329 (the “Policies”) by $5,000 each, and, in doing so, certified that Mr. Yuzwa was in good health. (ECF No. 22 {¥ 5, 13; ECF No. 23 {¥ 5, 13.) Defendant approved the applications and issued a $5,000 Term Life Insurance Rider on each of the Policies. (ECF No. 22 6, 14; ECF No. 23 {1 6, 14.) On July 7, 2016, Plaintiff signed an application seeking to increase coverage on Policy 008G98329 by $5,000, and, in doing so, certified that Mr. Yuzwa was in good health. (ECF No. 22 15; ECF No. 23 15.) Defendant approved the application, and, on July 23, 2016, Defendant issued a $5,000 Term Life Insurance Rider on Policy 008G98329. (ECF No. 22 { 16; ECF No. 23 { 16.) On August 2, 2017, Mr. Yuzwa died due to a gunshot wound to the head. (ECF No. 22 17; ECF No. 23 { 17.) On August 14, 2017, Defendant received a Proof of Death — Claimant’s Statement from Plaintiff. (ECF No. 22 J 18; ECF No. 23 ¥ 18.)

The Policies both contained incontestability provisions providing that: “We cannot contest this policy after it has been in force during the Insured’s lifetime for 2 years from the Policy Effective Date.” (ECF No. 22 J 19; ECF No. 23 J 19.) Mr. Yuzwa died within the contestability period set forth in the Policies, and Defendant was allowed to contest the Policies. (ECF No. 22 { 20; ECF No. 23 { 20.) 2. Defendant's Investigation Defendant initiated an investigation, and, on August 7, 2017, Defendant sent a letter to Plaintiff requesting various documents, including an AUTHORIZATION FOR RELEASE OF HEALTH INFORMATION PURSUANT TO HIPPA. (ECF No. 22 J 21; ECF No. 23 { 21.) On August 25, 2017, Defendant sent a letter to Plaintiff notifying her that “IT WILL BE NECESSARY FOR US TO REQUEST SOME INFORMATION FROM MEDICAL PROVIDERS THAT PROVIDED TREATMENT TO THE INSURED OVER THE PAST FEW YEARS.” (ECF No. 22 J 22; ECF No. 23 { 22.) On September 14, 2017, Defendant again wrote to Plaintiff to notify her that “ALL OR PART OF THE REQUESTED INFORMATION HAS NOT BEEN RECEIVED.” (ECF No. 22 J 23; ECF No. 23 { 23.) a. Records from Laurel Pediatric Associates As part of its investigation, Defendant obtained Mr. Yuzwa’s medical records from Laurel Pediatric Associates. (ECF No. 22 ] 24; ECF No. 23 { 24.) The records detail Mr. Yuzwa’s medical treatment from April 8, 2013, through April 7, 2015, in part as follows:

a. April 8, 2013 Chief Complaint—Possible Influenza. Assessment—cough, nausea alone, viral illness and contact or exposure to other viral disease. No medication prescribed. b. April 17, 2013 Chief Complaint—Possible Allergies. Assessment—allergic rhinitis cause uns, abdominal pain other site, headache. Prescribed cetirizine.

c. May 23, 2014 Chief Complaint—Stomach ache x 2 days. Assessment— □□□□□□□□□□□□□□□□□□□□□ abdominal pain epigastric, nausea with vomiting. Advised to take OTC Pepto Bism[o]l and OTC Probiotics. No medication, diagnostic testing, or follow-up treatment prescribed. d. November 22, 2014 Chief Complaint—Stomach cramps x “years.” Assessment— abdominal tenderness LLQ, Irritable Bowl Syndrome.! ¢ ! “[D]iscussed that diet is likely causing a great deal of his pain and discomfort.” “Foods containing glut[]en (wheat products) and dairy products can cause stomach issues.” No medication, diagnostic testing, or follow-up treatment prescribed. e. January 28, 2015 Chief Complaint—Fever and achiness since last night. Assessment — viral illness, nasal congestion, myalgia. f. February 17, 2015 Chief Complaint—Feeling achy today. Assessment— abdominal pain generalized, nausea alone, cough, headache. Advised he could take Tums or Aspirin-free Alka Seltzer and Tylenol if needed. g. March 31, 2015 Chief Complaint—School excuse needed. Was vomiting this morning, but is now resolved. Assessment—acute gastroenteritis, vomiting alone. No medication, diagnostic testing, or follow-up treatment prescribed. h.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Melrose, Inc. v. City of Pittsburgh
613 F.3d 380 (Third Circuit, 2010)
Amica Mut. Ins. Co. v. Fogel
656 F.3d 167 (Third Circuit, 2011)
Armbruster v. Unisys Corp.
32 F.3d 768 (Third Circuit, 1994)
United States Fire Ins Co v. Kelman Bottles
538 F. App'x 175 (Third Circuit, 2013)
Ruehl v. Viacom, Inc.
500 F.3d 375 (Third Circuit, 2007)
American Eagle Outfitters v. Lyle & Scott Ltd.
584 F.3d 575 (Third Circuit, 2009)
Jung v. Nationwide Mutual Fire Insurance
949 F. Supp. 353 (E.D. Pennsylvania, 1997)
Klinger v. State Farm Mutual Automobile Insurance
895 F. Supp. 709 (M.D. Pennsylvania, 1995)
O'Donnell Ex Rel. Mitro v. Allstate Insurance Co.
734 A.2d 901 (Superior Court of Pennsylvania, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
HORVATH v. GLOBE LIFE AND ACCIDENT INSURANCE COMPANY, Counsel Stack Legal Research, https://law.counselstack.com/opinion/horvath-v-globe-life-and-accident-insurance-company-pawd-2019.